Cambridge Healthtech Institute’s 9th Annual

Intensified & Continuous Processing

Accelerating Development & Reducing Timelines

August 14-15, 2023

The biopharma industry is driven by the need to increase productivity, reduce cost, while maintaining product quality and consistency. Continuous biomanufacturing and process intensification are borne out of such need. CHI’s Intensified & Continuous Processing conference looks at the challenges of developing and implementing continuous and intensified processing across up- and downstream processes, scalability from lab to clinic, and end-to-end integration. We are inviting case studies that illustrate strategies, solutions, technologies, and novel approaches to overcome these challenges.

Coverage will include, but is not limited to:

Perfusion and Process Intensification Solutions for Upstream Processing of mAb and non-mAb
Challenges of Downstream Continuous Biomanufacturing
Continuous Virus Inactivation
End-to-End Continuous Biomanufacturing
- Enabling complete, closed, and continuous processes in upstream and downstream processes
Moving from Lab Scale to Clinical and Commercial Scale
Process Validation of a Continuous Process
Continuous Processes in a Legacy Facility
Tools and Technologies for Continuous Monitoring and Control
- PAT Solutions to Support Continuous Processing
- AI/ML to enable data collection and analysis
- Predictive modeling and advanced process control
Sustainable Approaches to Reduce Carbon Emissions, Water Use, and Plastic Waste

The deadline for priority consideration is February 3, 2023.

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

Opportunities for Participation: